MAP1LC3B and breast carcinoma: First, we employed standard MAP1LC3B/LC3B-based autophagy assays as these have been used successfully to monitor autophagy in breast cancer cell lines, including in SKBR3 lines, and under similar stress conditions we employed [44–47].